Natural Sleep Aids for Elderly People with Heart Conditions: Why Finding What’s Stealing Your Sleep Matters More Than Finding Something to Take

Story-at-a-Glance

• Up to 75% of people with heart failure experience sleep problems, but the root cause matters more than the remedy — sleep apnea, medication side effects, and cardiac symptoms like orthopnea often masquerade as simple insomnia
• A November 2025 American Heart Association study revealed that long-term melatonin use was associated with higher rates of heart failure diagnosis and hospitalization in people with chronic insomnia
• Cognitive behavioral therapy for insomnia (CBT-I) improved six-minute walk distance by 100 feet in heart failure patients — equivalent to some drug and cardiac device trials — without medication risks
• Sleep-disordered breathing affects 40-80% of people with heart conditions, yet many remain undiagnosed because they don’t fit the “typical” profile of loud snoring or obesity
• Natural sleep aids including magnesium can interact with heart medications (especially diuretics), while valerian showed promise in cardiac surgery patients but lacks long-term safety data
• The most effective approach combines identifying why you’re not sleeping (sleep apnea screening, medication review, cardiac symptom management) with evidence-based behavioral strategies
• Heart failure medications themselves — including beta-blockers and diuretics — can paradoxically worsen sleep through melatonin suppression and nocturia

---

When 72-year-old Margaret’s cardiologist asked about her sleep during a routine heart failure follow-up, she almost didn’t mention it. After all, everyone her age had trouble sleeping, right? But when she finally described waking six times per night gasping for air, her cardiologist’s expression changed. “That’s not just insomnia,” he said quietly. Within a month, Margaret learned she had central sleep apnea — a common but often-missed condition in heart failure patients — and that her “sleep problem” was actually a window into her worsening cardiac function.

Margaret’s story, documented in research on sleep-disordered breathing in heart failure patients, illustrates a critical truth that gets lost in discussions about natural sleep aids for elderly people with heart conditions: before you try to fix your sleep, you need to understand why it’s broken.

The Question We Should Be Asking First

Here’s what keeps me up at night (professionally speaking): we’ve created an entire industry around “sleep aids” for people with heart conditions without adequately addressing a more fundamental question — what if your sleep problem is your heart problem?

Research published in the Journal of Clinical Sleep Medicine found that approximately 60% of people with heart failure report sleep disturbances, but here’s the kicker — these aren’t just separate conditions happening to coexist. They’re often bidirectionally connected, meaning your heart condition disrupts your sleep, which then worsens your heart condition, creating a vicious cycle.

Think about it: if your breathlessness when lying flat (orthopnea) is waking you up, will magnesium fix that? If your diuretic is sending you to the bathroom four times a night (nocturia), will melatonin address the root cause? If your beta-blocker is suppressing your natural melatonin production, as research has documented in heart failure patients, will chamomile tea restore it?

The answer, frustratingly, is: probably not in any meaningful way.

(This connection between reducing cardiovascular stress through anxiety management and sleep quality underscores why addressing root causes matters more than adding supplements.)

When “Natural” Doesn’t Mean “Harmless” — The Melatonin Wake-Up Call

In November 2025, researchers dropped a bombshell at the American Heart Association’s Scientific Sessions. Their study of over 130,000 adults with chronic insomnia found that those who used melatonin long-term (more than one year) had higher rates of heart failure diagnosis, heart failure hospitalization, and death from any cause compared to those who didn’t use melatonin.

Now, this doesn’t prove melatonin caused these outcomes — as lead researcher Dr. Ekenedilichukwu Nnadi cautioned, “worse insomnia, depression/anxiety or the use of other sleep-enhancing medicines might be linked to both melatonin use and heart risk.” But it does shatter the comfortable assumption that melatonin is universally safe, particularly for those with or at risk for heart conditions.

The concerning pattern: People take melatonin because they can’t sleep. They can’t sleep partly because their heart condition is worsening. The worsening heart condition then shows up in the statistics, but melatonin use becomes the marker we can measure. It’s a perfect example of why we need to look deeper than “take this supplement.”

The Hidden Epidemic: Sleep Apnea in Heart Patients

Here’s something that shocked me when I first encountered the research: between 40% and 80% of people with heart conditions have obstructive sleep apnea, according to the American Heart Association. Yet most remain undiagnosed.

Why? Because we’re looking for the wrong things. Dr. Kathleen Drinan, a cardiologist at the University of Chicago Medicine with over 30 years of experience, notes in her commentary on sleep and heart health that many cardiac patients don’t fit the “typical” sleep apnea profile — they may not snore loudly, they may not be obese, and with central sleep apnea (more common in heart failure), they may not snore at all.

Central sleep apnea occurs when the brain temporarily fails to signal the muscles to breathe — not because the airway is blocked, but because the damaged heart creates instability in breathing patterns. As documented in studies of sleep and heart failure, this creates a cascade: breathing stops → oxygen drops → blood pressure spikes → heart works harder → cardiac function worsens → sleep apnea gets worse.

Before reaching for valerian or magnesium, anyone with a heart condition who struggles with sleep needs proper evaluation for sleep-disordered breathing. This evaluation is essential. Period.

What Actually Works: The Evidence We Can’t Ignore

So if natural sleep aids aren’t the answer, what is?

Enter Nancy Redeker, PhD, RN, FAHA, FAAN, the Beatrice Renfield Term Professor of Nursing at Yale School of Nursing and a researcher who’s spent more than 25 years studying sleep in people with heart conditions. Her HeartSleep Study, published in the journal Sleep in 2022, provides some of the most compelling evidence we have.

Redeker’s team randomized 175 people with heart failure and insomnia to either cognitive behavioral therapy for insomnia (CBT-I) or standard heart failure self-management education. The results at one year? The CBT-I group showed sustained improvements in insomnia severity, sleep quality, fatigue, and — most impressively — a 100-foot improvement in six-minute walk distance, an objective measure of functional capacity.

“The most notable finding, actually, is the fact that we improved the six-minute walk test distance in these patients,” Redeker noted in an interview about the study. “And that’s important because that’s a real important marker of function. It’s not just a self-report, it’s an objective measure. We showed that improvement was equivalent to some drug trials and some cardiac device trials.”

Let that sink in for a moment. A behavioral intervention for sleep problems achieved functional improvements comparable to medications and medical devices.

But What About Natural Sleep Aids? (The Nuanced Reality)

I can already hear the pushback: “Are you saying natural sleep aids have no place for elderly people with heart conditions?”

Not exactly. What I’m saying is that their place is much smaller and more conditional than most people assume, and they should never be the first-line approach.

Let’s break down what the research actually shows:

Magnesium

Studies document that magnesium supplementation can improve sleep quality in older adults — in one randomized trial, 500mg daily for 8 weeks improved sleep time, sleep efficiency, and reduced insomnia severity in elderly participants.

But here’s the caveat for heart patients: Magnesium can interact with several cardiac medications, including diuretics (which many heart failure patients take). As documented in clinical reviews, people with kidney disease — common in heart failure patients — should take magnesium supplements with caution. They should only do so under medical supervision. The safe dose range is typically 200-400mg, but starting lower and monitoring is essential.

Valerian Root

Intriguingly, one study found that valerian improved sleep quality in people who had undergone heart surgery — 530mg nightly for 30 days led to significant improvements in sleep quality, latency, and duration compared to placebo.

The problem: We lack long-term safety data for valerian, particularly in elderly patients and those with complex medication regimens. Clinical reviews note uncertainty about valerian’s safety for extended use, and it can interact with sedatives and other medications.

Melatonin

Given the November 2025 findings, the melatonin story for heart patients has become considerably more complex. Canadian pharmacy researchers recommend that if melatonin is tried, it should be:

• Low dose (0.3mg to 2mg maximum)
• Given 1 hour before bedtime
• Products with a Natural Product Number (licensed by Health Canada)
• Stopped if adverse effects occur or lack of efficacy is noted

But they also emphasize something crucial: “Efficacy remains marginal, and more data from very elderly and fragile patients are required to assess efficacy and safety at low doses.”

For elderly people with heart conditions, melatonin should be considered experimental at best, with close medical supervision and only after other approaches have been tried.

The Medications You’re Already Taking Might Be the Problem

Here’s a twist that often gets overlooked: heart failure medications themselves can worsen sleep.

Beta-blockers, which many cardiac patients take, can suppress melatonin production — as documented in research on sleep and heart failure pharmacology, “the synthesis and secretion of melatonin, the sleep promoting hormone made by the pineal gland, is primarily regulated by the sympathetic nerves through the β-adrenergic signal transduction system and could be impaired by administration of β-blockers.”

Loop diuretics improve breathing and reduce sleep apnea severity (by reducing fluid overload), but they also cause nocturia — waking multiple times to urinate — which fragments sleep just as effectively.

This creates a maddening situation: the medications keeping you alive are also keeping you awake.

A Better Framework: The Detective Approach to Sleep Problems

Based on the research, here’s what an evidence-based approach looks like for elderly people with heart conditions struggling with sleep:

Step 1: Rule Out Cardiac Causes

• Is orthopnea (shortness of breath when lying flat) waking you?
• Are you experiencing paroxysmal nocturnal dyspnea (sudden breathlessness at night)?
• Does elevating the head of your bed help? If yes, you may need better heart failure management, not sleep aids

Step 2: Screen for Sleep-Disordered Breathing

• Ask your cardiologist about sleep apnea screening
• Many sleep studies can now be done at home — about 90% according to sleep specialists
• With heart failure, both obstructive AND central sleep apnea are possible

Step 3: Review ALL Medications

• Time diuretics earlier in the day if nocturia is an issue
• Discuss beta-blocker alternatives with your cardiologist if they’re affecting sleep
• Identify any medications with insomnia as a side effect

Step 4: Optimize Sleep Hygiene AND Cardiac Function

• Sleep hygiene matters, but it’s not magic
• Keep bedroom cool (helps both sleep and cardiac function)
• Elevate head of bed 30-45 degrees if needed
• Maintain consistent sleep schedule

Step 5: Consider Cognitive Behavioral Therapy for Insomnia

• As demonstrated in Redeker’s research, CBT-I is highly effective for heart failure patients
• It addresses perpetuating factors that maintain chronic insomnia
• Benefits are sustained over time
• No medication interactions or side effects

Only After Steps 1-5: Cautiously Consider Natural Sleep Aids

• Start with medical supervision
• Begin at lowest effective dose
• Monitor for side effects and interactions
• Recognize that efficacy may be modest
• Have a plan to discontinue if ineffective

The Conversation We Need to Have With Our Doctors

When Redeker interviewed heart failure patients for her research, they told her something revealing: they had major sleep problems, but healthcare providers rarely addressed it. As she noted, patients emphasized “the importance of sleep to their daily health and function and suggested the need for health care providers to help them address it.”

This is the advocacy piece. If you’re elderly with a heart condition and struggling with sleep, you need to:

1. Describe your sleep problems specifically — not just “I can’t sleep,” but “I wake gasping for air” or “I’m up six times to urinate” or “I can’t breathe when I lie flat”
2. Ask explicitly about sleep apnea screening — particularly if you have heart failure, atrial fibrillation, or poorly controlled blood pressure
3. Request a medication review focused on sleep impacts
4. Ask about CBT-I or behavioral sleep medicine specialists
5. Inquire about specialized cardiac-sleep clinics where cardiologists and sleep specialists work together

Some healthcare systems, like Austin Heart Sleep Disorders Center and Brigham and Women’s Hospital’s Healthy Sleep/Healthy Heart Clinic, now have integrated programs specifically for people with both cardiac and sleep issues. If these aren’t available near you, at minimum, your cardiologist should be coordinating with a sleep specialist.

The Connection Between Your Sleep and Heart Health Goes Both Ways

Recent research has revealed something both alarming and empowering about the sleep-heart connection. A 2023 study published in Sleep Medicine found that people who could fall asleep, stay asleep, and wake feeling rested were 30% less likely to die from any cause, 21% less likely to die from heart disease, and 19% less likely to die from cancer.

But here’s the flip side: Research presented at the American College of Cardiology in 2023 showed that people with insomnia were 69% more likely to have a heart attack compared to those without the sleep disorder during nine years of follow-up. Those sleeping five or fewer hours nightly had the greatest risk.

This bidirectional relationship — where heart disease causes sleep problems, and sleep problems worsen heart disease — is precisely why the “just take a supplement” approach is so inadequate. You’re trying to interrupt a complex pathophysiological process with a single intervention that doesn’t address the underlying mechanisms.

It’s like trying to fix a car’s engine problems by adding air freshener. Sure, the smell might improve, but the engine is still broken.

A Note on What We Don’t Know (And Why That Matters)

Let me be uncomfortably honest about the limitations of what we know: most natural sleep aid research has been conducted in younger, healthier populations. As Canadian researchers note in their review of melatonin in elderly patients, “Efficacy remains marginal, and more data from very elderly and fragile patients are required to assess efficacy and safety at low doses.”

The same applies to valerian, chamomile, magnesium, and virtually every other natural sleep remedy. We simply don’t have robust, long-term safety and efficacy data specifically for elderly people with complex cardiac conditions and multiple medications.

This isn’t an argument for never trying these interventions. It’s an argument for appropriate humility about what we’re recommending and heightened vigilance for adverse effects or lack of benefit.

Where This Leaves Us

After reviewing hundreds of studies and clinical observations, here’s what I believe the evidence tells us about natural sleep aids for elderly people with heart conditions:

1. The “natural sleep aid” framework itself is flawed for this population because it assumes the problem is simple insomnia when it’s often masked cardiac deterioration, medication effects, or sleep-disordered breathing
2. Proper diagnosis must precede treatment — this means sleep apnea screening, medication review, and cardiac symptom assessment
3. Cognitive behavioral therapy for insomnia has the strongest evidence base for people with heart conditions and should be first-line treatment
4. Natural sleep aids have a role, but it’s limited, conditional, and should be medically supervised — magnesium and valerian show some promise, but interactions and individual variation are significant concerns
5. Melatonin’s safety profile in elderly cardiac patients is more questionable than we previously assumed, particularly with long-term use
6. The most effective approach is integrated — combining optimal heart failure management, sleep-disordered breathing treatment when present, behavioral sleep strategies, and only then considering supplements if truly indicated

Moving Forward

If you’re elderly with heart conditions and struggling with sleep, you deserve better than a bottle of melatonin. You deserve better than just hoping for the best. You deserve:

• A thorough evaluation of why you’re not sleeping
• Screening for sleep-disordered breathing
• A medication review focused on sleep impacts
• Access to evidence-based behavioral sleep interventions
• Coordination between your cardiologist and sleep specialists
• If supplements are appropriate, medical supervision of their use

The conversation about sleep in heart disease is finally changing, thanks to researchers like Nancy Redeker and others who’ve demonstrated that sleep isn’t just a quality-of-life issue for cardiac patients — it’s a functional and survival issue.

As Dr. Henry Klar Yaggi, Redeker’s colleague and associate professor of medicine at Yale, puts it: “Sleep is really becoming this third pillar of health. We have diet and exercise, but sleep has been ignored or minimized for so many years, and we’re starting to realize it has huge implications for the well-being and health of individuals.”

The question isn’t whether natural sleep aids have a place — it’s whether they’re addressing what actually needs to be fixed. And for most elderly people with heart conditions, the answer is more complex than any supplement bottle will ever reveal.

What’s your next step? Start by having an honest conversation with your cardiologist about your sleep. Bring a sleep diary if possible. Be specific about symptoms. Ask about sleep apnea screening. Inquire about CBT-I. And if supplements come up, make sure they’re part of a comprehensive strategy — not a substitute for proper diagnosis and evidence-based treatment.

Your sleep matters. Your heart function matters. And the relationship between them matters most of all.

---

FAQ

Q: What does CBT-I (Cognitive Behavioral Therapy for Insomnia) involve?

A: CBT-I is a structured behavioral treatment that addresses the thoughts, behaviors, and environmental factors perpetuating insomnia. It typically includes sleep restriction (limiting time in bed to match actual sleep time), stimulus control (using the bed only for sleep), cognitive restructuring (addressing worries about sleep), and sleep hygiene education. Unlike medications, CBT-I addresses the root causes of chronic insomnia and has sustained effects. For heart failure patients, research shows it can be delivered in 4 bi-weekly group sessions over 8 weeks with lasting benefits for insomnia, fatigue, and physical function.

Q: What is orthopnea and why does it matter for sleep?

A: Orthopnea is shortness of breath that occurs when lying flat, a common symptom in heart failure. When you lie down, fluid that has pooled in your legs during the day returns to circulation, increasing the workload on an already-struggling heart. This can wake you gasping for air, but it’s not insomnia — it’s a sign your heart failure may be worsening. If elevating the head of your bed (using pillows or bed risers) helps you breathe and sleep better, this is crucial information for your cardiologist, as it suggests you may need adjustment of your heart failure medications.

Q: What is central sleep apnea and how is it different from obstructive sleep apnea?

A: Obstructive sleep apnea (OSA) occurs when throat muscles relax and physically block the airway during sleep, typically causing loud snoring. Central sleep apnea (CSA) occurs when the brain temporarily fails to send signals to breathing muscles — the airway isn’t blocked, but breathing stops anyway. CSA is much more common in heart failure patients (affecting up to 50% of those with congestive heart failure) because the damaged heart creates instability in breathing control. People with CSA may not snore at all and are often not overweight, making it easy to miss. Both types cause repeated drops in oxygen levels during sleep, which stress the cardiovascular system.

Q: What is nocturia and why do heart medications cause it?

A: Nocturia is the need to wake multiple times during the night to urinate. Loop diuretics (like furosemide/Lasix), commonly prescribed for heart failure to reduce fluid overload, cause increased urination. While these medications are essential for managing heart failure and can actually improve breathing during sleep by reducing fluid in the lungs, they fragment sleep by requiring frequent bathroom trips. Timing the medication earlier in the day (under medical supervision) can sometimes help, but the medication itself cannot be stopped without risking cardiac decompensation.

Q: What is the six-minute walk test and why does it matter?

A: The six-minute walk test measures how far a person can walk in 6 minutes at their own pace. It’s a validated objective measure of functional capacity widely used in cardiac and pulmonary settings. In heart failure research, improvements in six-minute walk distance correlate with better quality of life and outcomes. The fact that cognitive behavioral therapy for insomnia improved this measure by 100 feet in heart failure patients is significant because it demonstrates that better sleep translates to better real-world physical function — patients could literally do more in their daily lives.

Q: What does “sustained effects” mean in the context of insomnia treatment?

A: “Sustained effects” means the benefits of treatment continue long after the active treatment phase ends. In the HeartSleep Study, cognitive behavioral therapy for insomnia showed sustained improvements in sleep, fatigue, and function at 6 months and 12 months after treatment — unlike medications, which typically only work while you’re taking them and may lose effectiveness over time. This is particularly important for elderly patients with chronic conditions who need long-term solutions rather than short-term fixes.

Q: What is the hypothalamic-pituitary-adrenal (HPA) axis and why does it relate to sleep and heart disease?

A: The HPA axis is the body’s central stress response system, involving the hypothalamus (in the brain), pituitary gland, and adrenal glands. When activated, it releases cortisol and other stress hormones. Chronic insomnia can dysregulate the HPA axis, leading to elevated nighttime cortisol, increased blood pressure, insulin resistance, and inflammation — all of which accelerate cardiovascular disease progression. In people with heart failure, this creates a vicious cycle: heart disease disrupts sleep, disrupted sleep activates stress systems, and chronic stress activation worsens heart disease.

Q: What does it mean when research says a study “cannot prove causation”?

A: When researchers say a study shows an “association” but “cannot prove causation,” they mean the data shows two things occur together (like melatonin use and heart failure diagnosis) but cannot definitively prove one causes the other. There could be other factors: perhaps people who take melatonin have more severe insomnia because their heart failure is already worse; perhaps the underlying condition causing both the sleep problem and the heart problem is the real culprit. This is why we need randomized controlled trials (where people are randomly assigned to take or not take a treatment) to establish cause-and-effect relationships. The November 2025 melatonin study was observational, not randomized, which is why causation cannot be proven.

Q: What are NYHA functional classes in heart failure?

A: The New York Heart Association (NYHA) functional classification is a system for categorizing heart failure severity based on symptoms and physical activity limitations. Class I means no limitation (ordinary physical activity doesn’t cause symptoms). Class II means slight limitation (comfortable at rest, but ordinary activity causes symptoms). Class III means marked limitation (comfortable at rest, but less-than-ordinary activity causes symptoms). Class IV means inability to carry out any physical activity without symptoms, with symptoms present even at rest. Research shows insomnia severity correlates with worsening NYHA class — as heart failure progresses, sleep problems tend to worsen.

Q: What are aldosterone inhibitors and how do they affect sleep in heart failure?

A: Aldosterone inhibitors (like spironolactone) are medications that block aldosterone, a hormone that causes sodium retention, potassium loss, and cardiac remodeling. They’re used in heart failure to reduce mortality and improve cardiac function. Research suggests aldosterone excess may contribute to obstructive sleep apnea severity, so aldosterone inhibitors might have the dual benefit of improving both heart function and sleep-disordered breathing. However, like all medications, they must be carefully monitored for side effects, particularly potassium levels and kidney function.

Q: What is sleep efficiency and why is it measured in sleep research?

A: Sleep efficiency is calculated as: (total sleep time ÷ total time in bed) × 100. For example, if you spend 8 hours in bed but only sleep 6 hours, your sleep efficiency is 75%. Healthy sleep efficiency is typically 85% or higher. In insomnia research, sleep efficiency is a key outcome measure because it captures not just how long you sleep, but how efficiently you use your time in bed. People with chronic insomnia often have low sleep efficiency because they lie awake for extended periods. Cognitive behavioral therapy for insomnia specifically targets improving sleep efficiency through techniques like sleep restriction.

Q: What does “bidirectional relationship” mean when describing sleep and heart disease?

A: A bidirectional relationship means causation works in both directions: A causes B, and B also causes A, creating a reinforcing cycle. With sleep and heart disease, heart conditions disrupt sleep (through orthopnea, nocturia, sleep apnea, medication effects), AND poor sleep worsens heart disease (through sympathetic activation, inflammation, blood pressure surges, stress hormone release). This bidirectional cycle is why addressing sleep problems in cardiac patients isn’t just about comfort — it may actually slow disease progression. It also explains why simple sleep aids often fail: they don’t interrupt the pathophysiological mechanisms linking the two conditions.

Q: What is paroxysmal nocturnal dyspnea?

A: Paroxysmal nocturnal dyspnea (PND) is sudden, severe shortness of breath that wakes you from sleep, typically 1-2 hours after falling asleep. Unlike orthopnea (which is relieved by sitting up), PND often requires getting out of bed and moving around, and the breathing difficulty may take 15-30 minutes to resolve. It’s a classic symptom of heart failure and occurs when fluid that has redistributed during sleep overwhelms the heart’s pumping capacity. If you’re experiencing PND, this is a medical urgency requiring prompt cardiology evaluation — it’s a sign of inadequately controlled heart failure, not simple insomnia.

Q: What is the renin-angiotensin-aldosterone system (RAAS) and why does it matter for sleep?

A: The RAAS is a hormone system that regulates blood pressure and fluid balance. In heart failure, the RAAS becomes overactive, contributing to disease progression through vasoconstriction, sodium retention, and cardiac remodeling. Research has shown that insomnia is associated with activation of the RAAS, suggesting a biological link between poor sleep and cardiovascular harm. Many heart failure medications (ACE inhibitors, ARBs, aldosterone inhibitors) work by blocking different parts of the RAAS. Interestingly, research has found that successful insomnia treatment (with cognitive behavioral therapy) can affect biomarkers related to the RAAS, suggesting that improving sleep might have direct effects on these disease pathways.

Q: Why do elderly patients process medications differently, and how does this affect sleep aids?

A: Aging affects drug metabolism and clearance through several mechanisms: reduced liver and kidney function slow drug elimination, decreased body water increases drug concentration, and changes in brain chemistry increase sensitivity to side effects like confusion and falls. For sleep aids specifically, elderly patients reach higher peak concentrations with standard doses and take longer to clear the medication, increasing risk of residual daytime drowsiness, cognitive impairment, and falls. This is why geriatric specialists recommend “start low, go slow” with any medication in elderly patients — including supposedly safe supplements like melatonin, which can cause next-day effects in this population.

Q: What is meant by “perpetuating factors” in chronic insomnia?

A: Perpetuating factors are behaviors and thought patterns that develop in response to poor sleep but end up maintaining the insomnia even after the original cause resolves. Common perpetuating factors include: spending excessive time in bed trying to “catch up” on sleep (which decreases sleep efficiency), taking naps (which reduces homeostatic sleep drive), consuming caffeine to combat daytime fatigue (which worsens nighttime sleep), developing anxiety about sleep itself, and creating negative associations between the bedroom and wakefulness. Cognitive behavioral therapy for insomnia specifically targets these perpetuating factors, which is why its effects are sustained — it breaks the cycle that maintains chronic insomnia.

Q: What is sleep-disordered breathing and how is it different from insomnia?

A: Sleep-disordered breathing (SDB) is an umbrella term for conditions where breathing is abnormal during sleep, including obstructive sleep apnea, central sleep apnea, and sleep-related hypoventilation. SDB is fundamentally different from insomnia: insomnia is difficulty falling or staying asleep due to prolonged wakefulness, while SDB involves abnormal breathing during sleep that causes repeated brief arousals (which the person may not even remember). The two can coexist — you can have both SDB and insomnia — but they require different treatments. CPAP or other breathing support treats SDB; cognitive behavioral therapy treats insomnia. Using sleeping pills for undiagnosed SDB can actually be dangerous because it may suppress the arousal response that restores breathing.

Q: What is actigraphy and why is it used in sleep research?

A: Actigraphy uses a wrist-worn device (similar to a fitness tracker) that measures movement over multiple days and nights. Special algorithms interpret periods of activity versus rest to estimate sleep-wake patterns, sleep duration, sleep efficiency, and circadian rhythms. Unlike polysomnography (formal sleep study), actigraphy doesn’t measure brain waves or breathing, but it has the advantage of assessing sleep in the person’s natural environment over extended periods (typically 1-2 weeks). In heart failure research, actigraphy is valuable because it captures both sleep patterns and daytime activity levels — Nancy Redeker’s studies used actigraphy to objectively document sleep improvements with cognitive behavioral therapy.

Q: What is sympathetic nervous system activation and why does it matter for sleep and heart health?

A: The sympathetic nervous system is the “fight or flight” branch of the autonomic nervous system. When activated, it increases heart rate, blood pressure, and stress hormone release. Normally, sympathetic activity decreases during non-REM sleep (the body’s rest-and-digest mode), giving the cardiovascular system a chance to recover. But in sleep-disordered breathing, each apnea episode causes a surge of sympathetic activation — the body thinks it’s suffocating and responds with a stress reaction. In chronic insomnia, sympathetic activity remains elevated even during sleep. This constant sympathetic overdrive contributes to hypertension, heart rhythm problems, and progression of heart failure. It’s one mechanism explaining why poor sleep directly harms the cardiovascular system.